These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 8758815

  • 1. [Enhancement of antitumor effect of cisplatin on human ovarian cancer by cyclosporin A in vitro and in vivo].
    Zhou Y, Chen H, Yang Q.
    Zhonghua Fu Chan Ke Za Zhi; 1996 Jan; 31(1):25-8. PubMed ID: 8758815
    [Abstract] [Full Text] [Related]

  • 2. [Establishment of human ovarian cancer cisplatin resistant cell line COC1/DDP and its mechanism of resistance].
    Zhou Y, Chen H, Yang Q.
    Zhonghua Yi Xue Za Zhi; 1996 Sep; 76(9):680-3. PubMed ID: 9275551
    [Abstract] [Full Text] [Related]

  • 3. [Relationship between cytochrome c-mediated caspase-3 activity and chemoresistance in cisplatin-resistant human ovarian cancer cell lines].
    Yang X, Zheng F, Xing H, Gao Q, Wang W, Lu Y, Wang S, Ma D.
    Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):544-7. PubMed ID: 12667321
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Role of apoptosis-associated genes and caspase-3 in cisplatin-resistant human ovarian cancer cell lines].
    Yang XK, Xing H, Zheng F, Gao QL, Wang W, Lu YP, Ma D.
    Zhonghua Fu Chan Ke Za Zhi; 2003 Mar; 38(3):158-61. PubMed ID: 12816691
    [Abstract] [Full Text] [Related]

  • 6. [Study on curcumin-induced apoptosis in ovarian cancer resistant cell lines COC1/DDP].
    Lin L, Wang P, Zhao XL.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 May; 43(3):335-9. PubMed ID: 22812232
    [Abstract] [Full Text] [Related]

  • 7. Circumvention of cisplatin resistance in ovarian cancer by combination of cyclosporin A and low-intensity ultrasound.
    Yu T, Yang Y, Zhang J, He H, Ren X.
    Eur J Pharm Biopharm; 2015 Apr; 91():103-10. PubMed ID: 25668779
    [Abstract] [Full Text] [Related]

  • 8. [Effects of a protein kinase C inhibitor combined with cisplatin on non-small cell lung cancer].
    Gao ZQ, Han BH, Sha HF, Shi ZY, Yang XH, Feng JX.
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Apr; 33(4):284-8. PubMed ID: 20646461
    [Abstract] [Full Text] [Related]

  • 9. [Relationship between expression of apoptosis-associated proteins and caspase-3 activity in cisplatin-resistant human ovarian cancer cell line].
    Yang XK, Zheng F, Chen JH, Gao QL, Lu YP, Wang SX, Wang CY, Ma D.
    Ai Zheng; 2002 Dec; 21(12):1288-91. PubMed ID: 12520732
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Enhancement of antitumor effect of cisplatin against human ovarian carcinoma cells by mifepristone in vivo.
    Liu Y, Wang LL, Deng Y.
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Mar; 23(3):242-4. PubMed ID: 12651241
    [Abstract] [Full Text] [Related]

  • 13. [Effects of recombinant human interleukin-24 alone and in combination with cisplatin on the growth of ovarian cancer cells in vitro].
    Wang S, Guo J, Tang Y, Zheng R, Song M, Sun W.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jan; 30(1):33-6. PubMed ID: 24405596
    [Abstract] [Full Text] [Related]

  • 14. The enhanced antitumor effects of biodegradable cationic heparin-polyethyleneimine nanogels delivering HSulf-1 gene combined with cisplatin on ovarian cancer.
    Liu P, Gou M, Yi T, Qi X, Xie C, Zhou S, Deng H, Wei Y, Zhao X.
    Int J Oncol; 2012 Oct; 41(4):1504-12. PubMed ID: 22825572
    [Abstract] [Full Text] [Related]

  • 15. [Study on the effects of gonadotropin-releasing hormone analogues in the inhibition of ovarian cancer transplanted tumors and in the protection of ovarian function after chemotherapy on nude mice].
    Zhang Y, Lu ZY, Yan XH, Wang JJ, Feng WW, Ding JX, Hua Kq.
    Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):892-7. PubMed ID: 22333277
    [Abstract] [Full Text] [Related]

  • 16. [Effects of Zengmian Yiliu Recipe combined cisplatin on the tumor inhibition rate in platinum-resistant ovarian cancer].
    Qi C, Zhang QH, Li JX.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Jun; 32(6):817-21. PubMed ID: 22978111
    [Abstract] [Full Text] [Related]

  • 17. Regulation of HtrA2/Omi by X-linked inhibitor of apoptosis protein in chemoresistance in human ovarian cancer cells.
    Yang X, Xing H, Gao Q, Chen G, Lu Y, Wang S, Ma D.
    Gynecol Oncol; 2005 May; 97(2):413-21. PubMed ID: 15863139
    [Abstract] [Full Text] [Related]

  • 18. [Effects of suramin in combination with cisplatin on growth and metastasis of lung adenocarcinoma xenografts in mice].
    Zhang P, He JB, Ou LW, Wang XH.
    Ai Zheng; 2006 Apr; 25(4):409-13. PubMed ID: 16613671
    [Abstract] [Full Text] [Related]

  • 19. [Influence of mifepristone on DNA repair genes and cisplatin sensitivity in human ovarian cancer drug-resistance cells].
    Liu GY, Qu QX, Mi RR, Qi J.
    Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):132-5. PubMed ID: 18683754
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.